Free endothelium of the stump of the saphenofemoral junction and neoreflux/neoangiogenesis: A preliminary report;Freies endothel des magna-krossenstumpfes und neoreflux/neoangiogenese: Vorläufige mitteilung

Phlebologie

Volumn 33, Issue 5, 2004, Pages 156-159

  Frings, Norbert ^a   Tran, P ^a   Nelle, A ^a   Kohler L ^a  

^a Mosel Eifel Klinik   (Germany)

Author keywords

Neoangiogenesis; Neoreflux; Varicose vein surgery

Indexed keywords

ANGIOGENESIS; ARTICLE; COLOR ULTRASOUND FLOWMETRY; FEMORAL VEIN; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; POSTOPERATIVE PERIOD; PROSPECTIVE STUDY; SAPHENOUS VEIN; SURGICAL TECHNIQUE; VARICOSIS; VASCULAR ENDOTHELIUM; VEIN DIAMETER; VENOUS REFLUX;

EID: 7044286322     PISSN: 0939978X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1621555     Document Type: Article

References (33)

1. Betz E. Leistungen der Endothelzellen am Beispiel der Atherogenese. Phlebol Proktol 1990; 19: 153-8.
2. Bhatti TS, Whitmann B, Harradine K et al. Causes of re-recurrence after polytetrafluoroethylene patch saphenoplasty for recurrent varicose veins. Br J Surg 2000; 87: 1356-60.
3. Bradbury AW, Stonebridge PA, Callam MJ et al. Recurrent varicose veins: assessment of the saphenofemoral junction. Br J Surg 1994; 81: 373-5.
4. Creton D. Surgery for Recurrent saphenofemoral incompetence using expanded polytetrafluoroethylene patch interposition in front of the femoral vein: Long-term outcome in 119 extremities. Phlebology 2002; 16: 137-41.
5. Darke SG. The morphology of recurrent varicose veins. Eur J Vasc Surg 1992; 5: 512-7.
6. Earnshaw JJ, Heather BP. Neovascularisation as a cause of recurrent varicose veins. Scope Phlebol Lymphol 1999; 2: 20-3.
7. Fischer R, Linde N, Duff C et al. Late recurrent saphenofemoral junction reflux after ligation and stripping of the greater saphenous vein. J Vasc Surg 2001; 34: 236-40.
8. Fischer R, Chandler JG, De Maeseneer M et al. The unresolved problem of recurrent saphenofemoral reflux. J Am Coll Surg 2002; 195: 80-94.
9. Fischer R, Kluess HG, Frings N et al. Der aktuelle Stand der Magnakrossen-rezidiv-Forschung. Phlebologie 2003; 32: 54-9
10. Frings N, Tran VTP, Nelle A et al. Krossenrezidiv der V. saphena magna trotz korrekter Krossektomie: Neoangiogenese. Phlebologie 1999; 28: 144-8.
11. Frings N, Glowacki P, Nelle A et al. Prospektive Studie zur Verhinderung der Neoangiogenese nach Magna-Krossektomie. Erste Ergebnisse. Zentralbl Chir 2000; 126: 528-30.
12. Frings N, Nelle A, Tran VTP et al. Unvermeidbares Rezidiv und Neoreflux nach korrekter Vena-saphena-magna-Krossektomie: Neovaskularisation. Phlebologie 2003; 32: 96-100.
13. Gibbs PJ, Foy DMA, Darke SG. Reoperation for recurrent saphenofemoral incompetence: a prospective randomised trial using a reflected flap of pectineus fascia. Eur J Vasc Endovasc Surg 1999; 18: 494-8.
14. Glass GM. Neovascularization in recurrence of varices of the great saphenous vein in the groin. Phlebography. Angiology 1988; 39: 577-82.
15. Glass GM. Prevention of sapheno-femoral and sapheno-popliteal recurrence of varicose veins bei forming a partition to contain neovascularisation. Phlebology 1998; 13: 3-9.
16. Gorny PH, Reinharez D, Hutinel B et al. Chirurgie post-stripping en ambulatoire: Une étude sur 124 interventions et discussion sur la néogenèse. Phlébologie 1994; 47: 265-72.
17. Hach W, Hach-Wunderle V. Das theoretische Verständnis der »Rezidiwarikose nach Operation«. Gefäßchirurgie 1998; 3: 42-6.
18. Jones L, Braithwaite BD, Selwyn D et al. Neovascularisation is the principal cause of varicose vein recurrence: results of a rendomised trial of stripping the long saphenous vein. Eur J Vasc Endovasc Surg 1996; 12: 442-5.
19. Kluess HG, Mulkens P, Gallenkämper G et al. Die Rezidivvarikose- Einteilung nach Ursachen unter therapeutischen und prophylaktischen Gesichtspunkten. Phlébologie 1995; 24: 73.
20. Kluess HG, Gallenkämper G, Mulkens PJM et al. Die modifizierte Krossektomie der V. saphena magna - farbduplexsonographische Kontrolle nach zweieinhalb Jahren. Vasomed 1997; 4 (Suppl): 5.
21. Lefèbvre-Vilardebo M. Le carrefour saphénofémoral: Étude anatomique et concepts de prévention des récidives variqueuses. J Mal Vasc 1991; 16: 355-8.
22. Lefèbvre-Vilardebo M, Lemasle P. Post-surgical varicose veins recurrences: Neovascularisation or growth of preexisting lympho-nodal venous network? Int Angiol 2001; 20 (Suppl I): 299.
23. De Maeseneer MG, Ongena KP, Van den Brande F et al. Duplex ultrasound assessment of neovascularization after sapheno-femoral or sapheno-popliteal junction ligation. Phlebology 1997; 12: 64-8.
24. De Maeseneer MG, Giuliani DR, Van Schil PE et al. Can interposition of a silicone implant after sapheno-femoral ligation prevent recurrent varicose veins? Eur J Vasc Endovasc Surg 2002; 24: 445-9.
25. Mumme A, Olbrich S, Babera L et al. Saphenofemorales Leistenrezidiv nach Stripping der Vena saphena magna: technischer Fehler oder Neovaskularisation Phlebologie 2002; 31: 38-41.
26. Netzer CO, Schropp W. Varizenrezidiv nach korrekter operativer Behandlung. In: Netzer CO, Kleine MW (Hrsg). Phlebologische Therapie - Möglichkeiten und Grenzen unter Berücksichtigung kostendämpfender Maßnahmen. Stuttgart: Schattauer 1988: 12-23.
27. Nyamekye I, Shephard NA, Davies B et al. Clinicopathogical evidence that neovascularisation is a cause of recurrent varicose veins. Eur J Vasc Endovasc Surg 1998; 15: 412-5.
28. Perrin MR, Guex JJ, Ruckley CV et al. Recurrent varices after surgery (REVAS), a consensus document. Cardiovasc Surg 2000; 8: 233-45.
29. Starnes HF, Vallance R, Hamiltion DN. Recurrent varicose veins: a radiological approach to investigation. Clin Radiol 1984; 35: 95-9.
30. Tong Y, Royle J. Recurrent varicose veins following high ligation of long saphenous vein: a duplex ultrasound study. Cardiovasc Surg 1995; 3: 485-7.
31. Turton EP, Scott DJ, Richards SP et al. Duplex-derived evidence of reflux after varicose vein surgery: neoreflux or neovascularisation? Eur J Vasc Endovasc Surg 1999; 17: 230-3.
32. Viani MP, Poggi RV, Pinto A et al. Re-exploration of the saphenofemoral junction in the treatment of recurrent varicose veins. Int Surg 1996; 81: 382-4.
33. Witzenbichler B, Asahara T, Murohara T et al. Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia. Am J Pathol 1998; 153: 381-94.